The specificities of protein kinase inhibitors: an update.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Biochemical Journal

• Publication date

  2003-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1042/BJ20021535PMID 12534346PMCID PMC1223271
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ‘Insulin-like’ effects of lithium ion on isolated rat adipocytes II. Specific activation of glycogen synthase

  2004cited by this paper
• p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol

  2002cited by this paper
• Protein kinases — the major drug targets of the twenty-first century?

  2002cited by this paper
• An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMA-inducible 92-kDa type IV collagenase expression.

  2002cited by this paper
• Indirubins Inhibit Glycogen Synthase Kinase-3β and CDK5/P25, Two Protein Kinases Involved in Abnormal Tau Phosphorylation in Alzheimer's Disease

  2001cited by this paper
• TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells

  2001cited by this paper
• Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?

  2001cited by this paper
• c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis.

  2001cited by this paper
• Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate.

  2001cited by this paper
• Role of JNK in hypertonic activation of Cl(-)-dependent Na(+)/H(+) exchange in Xenopus oocytes.

  2001cited by this paper
• SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

  2001influential reference
• KT5823 Inhibits cGMP-dependent Protein Kinase Activity in Vitro but Not in Intact Human Platelets and Rat Mesangial Cells*

  2000cited by this paper
• Specificity and mechanism of action of some commonly used protein kinase inhibitors

  2000influential reference
• Specificity and mechanism of action of some commonly used protein kinase inhibitors.

  2000cited by this paper
• Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5/p25.

  2000cited by this paper
• SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling

  2000cited by this paper
• Inhibition of cyclin‐dependent kinases 2 and 4 activities as well as induction of cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (−)‐epigallocatechin‐3‐gallate

  1999cited by this paper
• Structural basis for selective inhibition of Src family kinases by PP1.

  1999cited by this paper
• Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172).

  1999cited by this paper
• Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases

  1999cited by this paper
• Use of a drug‐resistant mutant of stress‐activated protein kinase 2a/p38 to validate the in vivo specificity of SB 203580

  1999cited by this paper
• Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity.

  1999cited by this paper
• Adenovirus-mediated Gene Transfer of cGMP-dependent Protein Kinase Increases the Sensitivity of Cultured Vascular Smooth Muscle Cells to the Antiproliferative and Pro-apoptotic Effects of Nitric Oxide/cGMP*

  1998cited by this paper
• Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors.

  1998cited by this paper
• Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution.

  1998cited by this paper
• Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase*

  1998cited by this paper
• The involvement of protein kinase G in stimulation of neutrophil migration by endothelins.

  1998cited by this paper
• Regulation of Sensory Neuron Precursor Proliferation by Cyclic GMP‐Dependent Protein Kinase

  1998cited by this paper
• Acquisition of Sensitivity of Stress-activated Protein Kinases to the p38 Inhibitor, SB 203580, by Alteration of One or More Amino Acids within the ATP Binding Pocket*

  1998cited by this paper
• Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.

  1997cited by this paper
• Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor

  1996cited by this paper
• Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells.

  1996cited by this paper
• A molecular mechanism for the effect of lithium on development.

  1996cited by this paper
• A synthetic inhibitor of the mitogen-activated protein kinase cascade.

  1995cited by this paper
• SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1

  1995cited by this paper
• Control of p70 S6 kinase by kinase activity of FRAP in vivo

  1995cited by this paper
• PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*)

  1995cited by this paper
• Control of p70 S6 kinase by kinase activity of FRAP in vivo

  1995cited by this paper
• Inhibition of cyclin-dependent kinases by purine analogues.

  1994cited by this paper
• Tea and cancer.

  1993cited by this paper
• Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src

  1991cited by this paper
• Gonococcal infection within Scotland: Antigenic heterogeneity and antibiotic susceptibility of infecting strains

  1990cited by this paper
• Inositol phospholipid-dependent cellular signalling: opportunities for drug discovery.

  1990cited by this paper
• Inositol phospholipid-dependent cellular signalling: opportunities for drug discovery.

  1990cited by this paper
• Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase.

  1987cited by this paper

• A safe haven for cancer cells: tumor plus stroma control by DYRK1B

  2025cites this paper
• (R)-6-[N-(3-(4-chlorophenyl) propyl] derivative of (R)-roscovitine inhibits lung carcinoma progression via cyclin-dependent kinase suppression.

  2025cites this paper
• The Role of a Glucal-Based Molecule in the Reduction of Pancreatic Adenocarcinoma—An In Vitro and In Silico Approach

  2025cites this paper
• The role of Goldilocks protein kinase DYRK1A in embryonic development.

  2025cites this paper
• Biology and pharmacological inhibition of homeodomain-interacting protein kinases

  2025cites this paper
• Selective genetic inactivation of Caspase 8 in hepatocytes ameliorates progression of MASH following Jnk deficiency.

  2025cites this paper
• Wnt/β-Catenin Signaling Pathway Targeting Androgenetic Alopecia: How Far Can We Go Beyond Minoxidil and Finasteride?

  2025cites this paper
• Discovery of a novel RSK2 inhibitor for the treatment of metastatic pancreatic cancer

  2025cites this paper
• Unlocking the therapeutic potential of protein kinase inhibitors in neurodegenerative and psychiatric disorders

  2025cites this paper
• GSK3α negatively regulates GSK3β by decreasing its protein levels and enzymatic activity in mouse embryonic stem cells

  2025cites this paper
• Single-cell morphological tracking of cell states to identify small-molecule modulators of liver differentiation

  2025cites this paper
• Narrative review: The multifaceted benefits of wasabi herbal supplements: Enhancing immune function, cognitive performance, and physical endurance

  2025cites this paper
• Site-Specific Regulation of Tau phosphorylation by MAPK pathways during HFS-Induced synaptic plasticity in the Rat hippocampus.

  2025cites this paper
• SRC and ERK Regulate the Turnover of Cytoskeletal Keratin Filaments

  2025cites this paper
• A Comprehensive Investigation on the Role of Bioactives on DYRK1A to Avert Alzheimer’s Disease

  2025cites this paper
• Discovery of Dietary Plant Flavonols as Novel Potent Inhibitors Targeting DYRK1A Kinase

  2025cites this paper
• The calpain-mediated proteolytic cleavage peptide P10 modulates Tau phosphorylation in Alzheimer's disease.

  2025cites this paper
• Antidiabetic potential of Ficus septica targeting aldose reductase and glycogen synthase kinase 3β

  2025cites this paper
• Going beyond ATP binding site as a novel inhibitor design strategy for tau protein kinases in the treatment of alzheimer's disease: A review.

  2025cites this paper
• EGCG-like non-competitive inhibitor of DYRK1A rescues cognitive defect in a down syndrome model.

  2024cites this paper
• The expanding landscape of canonical and non-canonical protein phosphorylation.

  2024cites this paper
• The pyrazolo[4,3-c]pyrazole core as a novel and versatile scaffold for developing dual DYRK1A-CLK1 inhibitors targeting key processes of Alzheimer’s disease pathology.

  2024cites this paper
• A dual‐omics approach on the effects of fibroblast growth factor‐2 (FGF‐2) on ventral tegmental area dopaminergic neurons in response to alcohol consumption in mice

  2024cites this paper
• (±)‐Catechins inhibit prehaustorium formation in the parasitic weed Phelipanche ramosa and reduce tomato infestation

  2024cites this paper
• Phosphorylation by JNK switches BRD4 functions.

  2024cites this paper
• Promising therapeutic approaches in Down Syndrome: addressing parents' doubts

  2024cites this paper
• Development of 5-hydroxybenzothiophene derivatives as multi-kinase inhibitors with potential anti-cancer activity.

  2024cites this paper
• N-Benzylated 5-Hydroxybenzothiophene-2-carboxamides as Multi-Targeted Clk/Dyrk Inhibitors and Potential Anticancer Agents

  2024cites this paper
• Antimicrobial Peptide Pro10-1D Exhibits Anti-Allergic Activity: A Promising Therapeutic Candidate

  2024cites this paper
• MNK-driven eIF4E phosphorylation regulates the fibrogenic transformation of mesenchymal cells and chronic lung allograft dysfunction

  2024cites this paper
• Identifying bioactive phytoconstituents as C-terminal Src kinase inhibitors: a virtual screening and molecular simulation approach

  2023cites this paper
• Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders

  2023cites this paper
• Effects of Epigallocatechin-3-Gallate (EGCG) in Diabetes Mellitus as a DYRK1A inhibitor

  2023cites this paper
• Latonduine-1-Amino-Hydantoin Hybrid, Triazole-Fused Latonduine Schiff Bases and Their Metal Complexes: Synthesis, X-ray and Electron Diffraction, Molecular Docking Studies and Antiproliferative Activity

  2023cites this paper
• HER2-driven breast cancer suppression by the JNK signaling pathway

  2023cites this paper
• Pharmacological approaches to understanding protein kinase signaling networks

  2023cites this paper
• Comparative Efficacy and Selectivity of Pharmacological Inhibitors of DYRK and CLK Protein Kinases.

  2023cites this paper
• Pan Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer

  2023cites this paper
• Tyrosine hydroxylase phosphorylation is under the control of serine 40

  2023cites this paper
• Unbiased evaluation of rapamycin's specificity as an mTOR inhibitor

  2023cites this paper
• Development of Novel Fluorinated Polyphenols as Selective Inhibitors of DYRK1A/B Kinase for Treatment of Neuroinflammatory Diseases including Parkinson’s Disease

  2023cites this paper
• Function and Inhibition of DYRK1A: emerging roles of treating multiple human diseases.

  2023cites this paper
• An Improved Protocol for the Matrigel Duplex Assay: A Method to Measure Retinal Angiogenesis

  2023cites this paper
• Effects of Inhibition of IKK Kinase Phosphorylation On the Cellular Defence System and HSP90 Activity

  2023cites this paper
• In-silico study for African plants with possible beta-cell regeneration effect through inhibition of DYRK1A

  2022cites this paper
• The Src-Kinase Fyn is Required for Cocaine-Associated Memory Through Regulation of Tau

  2022cites this paper
• Crystal structure of the Rho-associated coiled-coil kinase 2 inhibitor belumosudil bound to CK2α

  2022cites this paper
• A critical update on the strategies towards small molecule inhibitors targeting Serine/arginine-rich (SR) proteins and Serine/arginine-rich proteins related kinases in alternative splicing.

  2022cites this paper
• The microtubule network enables Src kinase interaction with the Na,K-ATPase to generate Ca2+ flashes in smooth muscle cells

  2022influential citation
• Epigallocatechin gallate is a potent inhibitor of cystathionine beta-synthase: Structure-activity relationship and mechanism of action.

  2022cites this paper
• Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics

  2022cites this paper
• Non-kinase targeting of oncogenic c-Jun N-terminal kinase (JNK) signaling: the future of clinically viable cancer treatments

  2022cites this paper
• In silico identification of chemical compounds in Spondias mombin targeting aldose reductase and glycogen synthase kinase 3β to abate diabetes mellitus

  2022cites this paper
• The Role of NO/sGC/cGMP/PKG Signaling Pathway in Regulation of Platelet Function

  2022cites this paper
• Discovery of novel 5-methoxybenzothiophene hydrazides as metabolically stable Clk1 inhibitors with high potency and unprecedented Clk1 isoenzyme selectivity.

  2022cites this paper
• Src family kinase targeting in head and neck tumor cells using SU6656, PP2 and dasatinib

  2022cites this paper
• Multi-Level High-Throughput Screening for Discovery of Ligands That Inhibit Insulin Aggregation.

  2022cites this paper
• Fyn nanoclustering requires switching to an open conformation and is enhanced by FTLD-Tau biomolecular condensates

  2022cites this paper
• CDK5/p35-Dependent Microtubule Reorganization Contributes to Homeostatic Shortening of the Axon Initial Segment

  2022cites this paper
• An overview of cdc2‐like kinase 1 (Clk1) inhibitors and their therapeutic indications

  2022cites this paper
• Straightforward Access to a New Class of Dual DYRK1A/CLK1 Inhibitors Possessing a Simple Dihydroquinoline Core

  2022influential citation
• Influenza A virus activates cellular Tropomyosin receptor kinase A (TrkA) signaling to promote viral replication and lung inflammation

  2022cites this paper
• Comprehensive Evaluation of Rapamycin’s Specificity as an mTOR Inhibitor

  2022cites this paper
• Increased dosage and treatment time of Epigallocatechin-3-gallate (EGCG) negatively affects skeletal parameters in normal mice and Down syndrome mouse models

  2022cites this paper
• Design, synthesis, and biological evaluation of polyphenol derivatives as DYRK1A inhibitors. The discovery of a potentially promising treatment for Multiple Sclerosis.

  2022cites this paper
• Downregulation of Diacylglycerol Kinase Delta Contributes to Hyperglycemia-Induced Insulin Resistance.

  2022cites this paper
• Catechins as a Potential Dietary Supplementation in Prevention of Comorbidities Linked with Down Syndrome

  2022cites this paper
• Regeneration of Pancreatic β-Cells for Diabetes Therapeutics by Natural DYRK1A Inhibitors

  2022influential citation
• Dynamics of Neo-Liberal Workplace and Employment Relations: Implications and Challenges to Social Partners

  2022cites this paper
• Enriching Chemical Space of Bioactive Scaffolds by New Ring Systems: Benzazocines and Their Metal Complexes as Potential Anticancer Drugs

  2022cites this paper
• Polyphenols and neuroprotection: Therapeutic implications for cognitive decline.

  2021cites this paper
• Protein Kinase A – Mediated Effects of Protein Kinase C Partial Agonist 5-(Hydroxymethyl)Isophthalate 1a3 in Colorectal Cancer Cells S

  2021cites this paper
• RSK1 vs. RSK2 Inhibitory Activity of the Marine β-Carboline Alkaloid Manzamine A: A Biochemical, Cervical Cancer Protein Expression, and Computational Study

  2021cites this paper
• Tumor Necrosis Factor Alpha Effects on the Porcine Intestinal Epithelial Barrier Include Enhanced Expression of TNF Receptor 1

  2021cites this paper
• 3‐phosphoinositide‐dependent protein kinase 1 (PDK1) mediates crosstalk between Src and Akt pathways in MET receptor signaling

  2021cites this paper
• Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer

  2021cites this paper
• Novel Mechanism for an Old Drug: Phenazopyridine is a Kinase Inhibitor Affecting Autophagy and Cellular Differentiation

  2021cites this paper
• Regulation of mRNA Translation by Hormone Receptors in Breast and Prostate Cancer

  2021cites this paper
• Anticancer potential of indirubins in medicinal chemistry: Biological activity, structural modification, and structure-activity relationship.

  2021cites this paper
• Discovery of Hydroxybenzothiazole Urea Compounds as Multitargeted Agents Suppressing Major Cytotoxic Mechanisms in Neurodegenerative Diseases.

  2021cites this paper
• Oximes: Novel Therapeutics with Anticancer and Anti-Inflammatory Potential

  2021influential citation
• Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview

  2021cites this paper
• Irreversible JNK blockade overcomes PD-L1-mediated resistance to chemotherapy in colorectal cancer

  2021cites this paper
• GSK-3β, FYN, and DYRK1A: Master Regulators in Neurodegenerative Pathways

  2021cites this paper
• Antiplatelet Effect of Nobiletin is Mediated by Activation of A2A Adenosine Receptor

  2021cites this paper
• 5-Methoxybenzothiophene-2-Carboxamides as Inhibitors of Clk1/4: Optimization of Selectivity and Cellular Potency

  2021cites this paper
• Activation of Interferon Signaling in Chronic Lymphocytic Leukemia Cells Contributes to Apoptosis Resistance via a JAK-Src/STAT3/Mcl-1 Signaling Pathway

  2021cites this paper
• Epigallocatechin-3-Gallate Plus Omega-3 Restores the Mitochondrial Complex I and F0F1-ATP Synthase Activities in PBMCs of Young Children with Down Syndrome: A Pilot Study of Safety and Efficacy

  2021influential citation
• Green tea extracts containing epigallocatechin-3-gallate modulate facial development in Down syndrome

  2021cites this paper
• Protein Kinase A–Mediated Effects of Protein Kinase C Partial Agonist 5-(Hydroxymethyl)Isophthalate 1a3 in Colorectal Cancer Cells

  2021cites this paper
• JNK1 signaling in the proximal tubule causes cell death and acute renal failure in rat and mouse models of renal ischaemia/reperfusion injury.

  2021cites this paper
• Phosphorylation of MYL12 by Myosin Light Chain Kinase Regulates Cellular Shape Changes in Cochlear Hair Cells

  2021cites this paper
• Transcription Factor 21 Promotes Chicken Adipocyte Differentiation at Least in Part via Activating MAPK/JNK Signaling

  2021cites this paper
• Antiplatelet Effect of Nobiletin is Mediated by Activation of A2A Adenosine Receptor

  2021cites this paper
• MAP kinases in regulation of NOX activity stimulated through two types of formyl peptide receptors in murine bone marrow granulocytes.

  2021cites this paper
• Potential and limitations of PKA/ PKG inhibitors for platelet studies

  2021cites this paper
• A MEKK1 – JNK mitogen activated kinase (MAPK) cascade module is active in Echinococcus multilocularis stem cells

  2021cites this paper
• A natural compound harmine decreases melanin synthesis through regulation of the DYRK1A/NFATC3 pathway.

  2021cites this paper
• Dyrk1a from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome

  2021cites this paper
• Applying Nanotechnology in the Synthesis of Benzimidazole Derivatives: A Pharmacological Approach

  2021cites this paper